Fifteen years' single-center experience with the ATS bileaflet valve

Journal of Heart Valve Disease

Volumn 18, Issue 4, 2009, Pages 444-452

  Van Nooten, Guido J ^a   Caes, Frank ^a   François, Katrien ^a   Van Belleghem, Yves ^a   Bové, Thierry ^a   Vandenplas, Guy ^a   De Pauw, Michel ^a   Taeymans, Yves ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; FEMALE; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROSTHESIS; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

AGED; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 79959338960     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Nooten G, Caes F, François K, Missault L, Van Belleghem Y. Clinical experience with the first 100 ATS Heart valve implants. Cardiovasc Surg 1996; 4:288-292
2. Emery R, Van Nooten GJ, Tesar PJ. The initial experience with the ATS Medical mechanical cardiac valve prosthesis. Ann Thorac Surg 2003; 75:444-452
3. Westaby S, Van Nooten G, Sharif H, Pillai R, Caes F. Valve replacement with the ATS open pivot bileaflet prosthesis. Eur J Cardiothorac Surg 1996; 10:660-665
4. Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008; 85:1490-1495
5. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: A 25-year experience with single valve replacement. Ann Thorac Surg 2005; 79:776-782; discussion 782-783
6. Bernet FH, Baykut D, Grize L, Zerkowski HR. Single-center outcome analysis of 1,161 patients with St. Jude Medical and ATS open pivot mechanical heart valves. J Heart Valve Dis 2007; 12:151-158
7. Dalrymple-Hay MJ, Pearce RK, Dawkins S, et al. Mid-term results with 1,503 CarboMedics mechanical valve implants. J Heart Valve Dis 2000; 9: 389-395
8. Bryan AJ, Rogers CA, Bayliss K, Wild J, Angelini GD. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: Ten-year follow-up. J Thorac Cardiovasc Surg 2007; 133:614-622
9. http://www.nationmaster.com/graph/hea-lifeexpectancy-birth-years
10. De Feo M, Onorati F, Renzulli A, et al. Mechanical prosthesis is still a valid option for aortic valve replacement in the elderly. J Heart Valve Dis 2004; 13:103-108
11. Emery RW, Emery AM, Krogh C, et al. The St. Jude Medical cardiac valve prosthesis: Long-term follow up of patients having double valve replacement. J Heart Valve Dis 2007; 16:634-640
12. Del Rizzo DF, Freed D, Abdoh A, et al. Midterm survival of stented versus stentless valves: Does concomitant coronary artery bypass grafting impact survival? Semin Thorac Cardiovasc Surg 2001; 13:148-155
13. Lengyel M. Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther 2008; 6:85-93
14. Diirrleman N, Pellerin M, Bouchard D, et al. Prosthetic valve thrombosis: Twenty-year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg 2004; 127:1388-1392
15. Kuntze C, Ebels T, Eijgelaer A, Homan Van Der Heide JN. Rates of thromboembolism with three different mechanical heart valve prosthesis; a randomised study. Lancet 1989; 11:514-517
16. Emery RW, Emery AM, Raikar GV, Shake JG. Anticoagulation for mechanical heart valves: A role for patient based therapy. J Thromb Thrombolysis 2008; 25:18-25
17. Albers GW. Warfarin prevails for stroke prevention in atrial fibrillation even in octogenarians. Lancet Neurol 2007; 6:844-846
18. Aagaard J, Tingleff J. Fifteen years' clinical experi- ence with the CarboMedics prosthetic heart valve. J Heart Valve Dis 2005; 14:82-88
19. Lund O, Nielsen SL, Arildsen H, Ilkjaer LB, Pilegaard HK. Standard aortic St. Jude valve at 18 years: Performance profile and determinants of outcome. Ann Thorac Surg 2000; 69:1459-1465
20. Van Nooten GJ, Van Belleghem Y, Caes F, et al. Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003; 12:495-501; discussion 502
21. Koertke H, Zittermann A, Tenderich G, et al. Lowdose oral anticoagulation in patients with mechanical heart valve prostheses: Final report from the early self-management anticoagulation trial II. Eur Heart J 2007; 28:2479-2484
22. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis. J Am Coll Cardiol 2001; 37:569-578
23. Arom KV, Emery RW, Nicoloff DM, Petersen RJ. Anticoagulant related complications in elderly patients with St. Jude mechanical valve prostheses J Heart Valve Dis 1996; 5:505-510